Top Markets
Coin of the day
Biostax Corp. Biostax Corp.

Biostax Corp.

BTAX
Classificação em ações #41904
Biostax Corp. is a biopharmaceutical enterprise dedicated to the acquisition,... Biostax Corp. is a biopharmaceutical enterprise dedicated to the acquisition, advancement, and commercialization of various pharmaceutical and biotechnology solutions. A pivotal focus lies on Lodonal, their lead investigational drug candidate, designed as a once-daily immune system modulator aimed at managing both human immunodeficiency virus and acquired immune deficiency syndrome (HIV/AIDS). Beyond this primary drug, their portfolio encompasses several innovative programs. These include a Global Telehealth platform and an early-stage Medtech initiative leveraging blockchain and smart contract technologies to enhance the security and management of prescriptions and electronic health records. Furthermore, Biostax is developing JKB-122, an experimental small molecule that acts as a long-duration toll-like receptor 4 (TLR4) antagonist, intended for the treatment of autoimmune hepatitis, nonalcoholic fatty liver disease (NAFLD), and nonalcoholic steatohepatitis (NASH). Another compound they address is Low Dose Naltrexone, a formula believed to offer immune-modulating advantages pertinent to conditions such as cancer, chronic pain, autoimmune disorders, and anti-aging efforts. The company also pursues development efforts for addressing hyperphosphatemia. Biostax maintains a licensing agreement with Cytocom Inc. and underwent a corporate name change from Immune Therapeutics, Inc. to its current designation in October 2023. The company's operational base is located in Winter Park, Florida.
Preço da ação
$0.0001
Última sincronização: 2026-08-11
Valor de mercado
$7.87K
Variação (1 dia)
0.00%
Variação (1 ano)
-50.00%
País
US
Negociar Biostax Corp. (BTAX)

Categoria

Preço BTAX com a capitalização de mercado de B
Biostax Corp. Biostax Corp.
BTAX
$0.0001
Capitalização de mercado de Biostax Corp.(BTAX)
Valor de mercado: $7.87K
Em August 2026, Biostax Corp. tem uma capitalização de mercado de $7.87K. Isso faz com que Biostax Corp. seja a 41904th empresa mais valiosa do mundo em termos de capitalização de mercado, de acordo com os nossos dados. A capitalização de mercado, também chamada de market cap, é o valor total de mercado das ações em circulação de uma empresa de capital aberto e é amplamente utilizada para medir o valor de uma empresa.
Histórico de capitalização de mercado de Biostax Corp. de 2010 a 2026
BTAX comparado com o topo de 5 mais populares stocks
Preço para BTAX Ativo B Capitalização de mercado de B Resultados
Biostax Corp. Biostax Corp.
$68,394.86 $7.87K
$5.383T +68,394,860,273.52%
Biostax Corp. Biostax Corp.
$56,198.59 $7.87K
$4.423T +56,198,592,248.34%
Biostax Corp. Biostax Corp.
$52,856.94 $7.87K
$4.160T +52,856,935,474.67%
Biostax Corp. Biostax Corp.
$46,542.00 $7.87K
$3.663T +46,542,000,115.98%
Biostax Corp. Biostax Corp.
$36,732.67 $7.87K
$2.891T +36,732,674,215.84%